HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis

Amiri, Fahimeh Bagheri; Mostafavi, Ehsan; Mirzazadeh, Ali

doi:10.1371/journal.pone.0151946

Cited by 77 publications

(67 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent national estimate of HCV prevalence among PWID was 51.46% (95% CI, 34.30 -68.62) (31). In the present study, we found an HCV antibody prevalence of 54.8% (95% CI, 50.8 to 58.7) in the PWID samples.…”

Section: Prevalence Of Hcv Antibodiessupporting

confidence: 62%

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

et al. 2017

View full text Add to dashboard Cite

Background: Infection with hepatitis C virus (HCV) is increasingly recognized as a major global health problem. Objectives: The aim of this study was to measure the prevalence of HCV infection and determine the risk factors associated with HCV among male people who inject drugs (PWID) in Kermanshah, Iran. Methods: In this cross sectional study, the samples were recruited from 2 drop-in centers and related community outreach sites, using snowball sampling. The questionnaire consisted of 3 sections, including demographics, drug use patterns, and risky behaviors. HCV infection was tested in venous blood samples, collected from the participants, using the ABON rapid test kit. Logistic regression analysis was used to determine the association between HCV status and the associated factors, reported as odds ratio (OR) and 95% confidence interval (CI).

show abstract

Section: Prevalence Of Hcv Antibodiessupporting

confidence: 62%

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Patients who received multiple transfusions (PWRMT) and prisoners had a low prevalence as 0.01% and 0.28%, not statistically different from the prevalence in the general population. Those finding were similarly this study which found 0.26% of triple co-infections in MSM group, but they found in people who inject drug (Fahimeh, 2016).…”

Section: Discussionsupporting

confidence: 82%

The associated factors of HBV and/or HCV with HIV co-infection among men who have sex with men (MSM) in the Northern region of Thailand, 2015

Wongwichit¹,

Singharachai²,

Suwanaporn³

et al. 2017

jmms

View full text Add to dashboard Cite

Men who have sex with men (MSM) are at higher risk for co-infection with hepatitis B virus (HBV), hepatitis C virus (HCV) than the general population. The co-infection accelerates disease progressionreciprocally. This study purposed to investigate the prevalence and the associated factors with HBV and/or HCV co-infection with HIV among MSM in Northern region Thailand in 2015. A case-control study design was conducted by a hospital-based in anti-retroviral (ARV) clinic. 31 of 51 hospitals in the Phayao, Chiang Mai and Chiang Rai province were recruited in this study. The result was found 374 total participants who were registered patients in ARV clinic inPhayao84 cases (22.5 %), Chiang Mai 170 (45.5%) and Chiang Rai120 (32.1%). The participants were 30-43 year old (47.1%), followed by 16-29 years old (29.9%), and 44-57 years old (19.8%). The majority of occupational were employee (50.0%), follow by merchant (24.9%) and agriculturist (9.4%).The univariate analysis with a significant α level of 0.05were found six factors had significantly association with HBV and/or HCV with HIV co-infection including (1) age range (2) smoking behavior (3) tongue piercing, (4) Stavudine drug taking, (5) Tenofivir drug taking and (6) Nevirapine drug taking. Moreover, the binary logistic regression at a significant α level of 0.05, after controlling for all possible confounding factors, were found four factors significantly association with co-infection including (1) age between 30-43 year old had the risk of co-infection 2.42 times [odds ratio (OR) = 2.42, 95% confidence interval (CI) = 1.14-5.14] higher than those who had age range 16-29 year old, (2) smoking behavior in the participants had the risk of co-infection 2.05 times (OR = 2.05, 95% CI = 1.12-3.76) higher than no smoking behavior. (3)Tongue piercing in the participants had the risk of co-infection 6.82 times (OR = 6.70, 95% CI = 1.12-40.19) higher than no tongue piercing and (4) Tenofivir drug taking had the risk of co-infection 4.30 (OR = 4.30, 95% CI = 2.37-7.84) more than no taking drug. Therefore, enhancing the surveillance and targeted prevention of viral hepatitis including improved disease prevention, vaccination coverage, sanitation and food safety, safer sex and efficiency healthcare delivery,

show abstract

“…The attributed effects of risk factors vary across different regions, depending on the epidemiologic distribution and prevalence of the risk factors in each region (25,27,30,(36)(37)(38). In the United States, Europe, and Japan, 22% of the cases of primary liver cancer are attributed to hepatitis B, while 60% are attributed to hepatitis C, and 43% are attributed to alcohol consumption.…”

Section: Discussionmentioning

confidence: 99%

Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis

et al. 2018

View full text Add to dashboard Cite

Background: Liver cancer is a highly lethal cancer with 5 year survival rate of about 18%. This cancer is a leading cause of death in many countries. As there is not a comprehensive population base study on liver cancer mortality rates by cause in national and provincial level in Iran. We aimed to estimate the liver cancer mortality rate, its patterns, and temporal trends during 26 years by sex, age, geographical distribution, and cause. Methods: We used the Iranian death registration system (DRS), in addition to demographic and statistical methods, to address the incompleteness and misclassification and uncertainty of death registration system to estimate annual liver cancer mortality rate. Direct age standardized approach was applied using Iran national population 2015 as a standard population to facilitate the comparison between the provinces. Results: Liver cancer age standardized mortality rate in Iran increased by more than four times from 1.18 (95% uncertainty interval; 0.86 to 1.61) deaths per 100,000 person in 1990 to 5.66 (95% uncertainty interval; 4.20 to 7.63) deaths per 100,000 person in 2015. Male to female age adjusted mortality ratio changed from 0.87 to 1.82 during the 26 years of the study. With increasing age, liver cancer mortality rate increased in both sex and all provinces. At provincial level, the province with highest mortality rate have 2.96 times greater rate compare to the lowest. Generally, about 71% of mortality at national level is due to hepatitis B and C infection. Conclusions: In order to reduce liver cancer mortality rate, it is recommended to control main risk factors including chronic hepatitis infections. Because of the growing rate of mortality from liver cancer, augmenting life expectancy, and increasing number of the elderly in Iran, policy makers are more expected to adopt measures including hepatitis B vaccination or hepatitis C treatment.

show abstract

HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis

Cited by 77 publications

References 23 publications

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

The associated factors of HBV and/or HCV with HIV co-infection among men who have sex with men (MSM) in the Northern region of Thailand, 2015

Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis

Contact Info

Product

Resources

About